{"$schema":"https://www.lobbyregister.bundestag.de/json-schemas/R2.22/Lobbyregister-Registereintrag-schema-R2.22.json","source":"Deutscher Bundestag, Lobbyregister für die Interessenvertretung gegenüber dem Deutschen Bundestag und der Bundesregierung","sourceUrl":"https://www.lobbyregister.bundestag.de","sourceDate":"2026-05-26T00:20:51.527+02:00","jsonDocumentationUrl":"https://www.lobbyregister.bundestag.de/informationen-und-hilfe/open-data-1049716","registerNumber":"R004185","registerEntryDetails":{"registerEntryId":66383,"legislation":"GL2024","version":5,"detailsPageUrl":"https://www.lobbyregister.bundestag.de/suche/R004185/66383","pdfUrl":"https://www.lobbyregister.bundestag.de/media/79/cc/626483/Lobbyregister-Registereintraege-Detailansicht-R004185-2025-10-07_13-52-35.pdf","validFromDate":"2025-10-07T13:52:35.000+02:00","fiscalYearUpdate":{"updateMissing":false,"lastFiscalYearUpdate":"2025-07-21T15:42:34.000+02:00"}},"accountDetails":{"activeLobbyist":true,"activeDateRanges":[{"fromDate":"2024-06-25T14:46:47.000+02:00"}],"firstPublicationDate":"2022-04-13T08:54:44.000+02:00","lastUpdateDate":"2025-10-07T13:52:35.000+02:00","registerEntryVersions":[{"registerEntryId":66383,"jsonDetailUrl":"https://www.lobbyregister.bundestag.de/sucheJson/R004185/66383","version":5,"legislation":"GL2024","validFromDate":"2025-10-07T13:52:35.000+02:00","versionActiveLobbyist":true},{"registerEntryId":53335,"jsonDetailUrl":"https://www.lobbyregister.bundestag.de/sucheJson/R004185/53335","version":4,"legislation":"GL2024","validFromDate":"2025-07-21T15:42:34.000+02:00","validUntilDate":"2025-10-07T13:52:35.000+02:00","versionActiveLobbyist":true},{"registerEntryId":35464,"jsonDetailUrl":"https://www.lobbyregister.bundestag.de/sucheJson/R004185/35464","version":3,"legislation":"GL2024","validFromDate":"2024-06-25T14:46:47.000+02:00","validUntilDate":"2025-07-21T15:42:34.000+02:00","versionActiveLobbyist":true}],"accountHasCodexViolations":false},"lobbyistIdentity":{"identity":"ORGANIZATION","name":"Valneva SE","legalFormType":{"code":"JURISTIC_PERSON","de":"Juristische Person","en":"Legal person"},"legalForm":{"code":"LF_SE","de":"Europäische Aktiengesellschaft (SE)","en":"European stock company (SE)"},"contactDetails":{"phoneNumber":"+33228073710","emails":[{"email":"info@valneva.com"}],"websites":[{"website":"https://valneva.com/"}]},"address":{"type":"FOREIGN","internationalAdditional1":"6 rue Alain Bombard","city":"44800 Saint-Herblain","country":{"code":"FR","de":"Frankreich","en":"France"}},"capitalCityRepresentationPresent":false,"legalRepresentatives":[{"academicDegreeBefore":"DI","lastName":"Lingelbach","firstName":"Thomas","function":"CEO","recentGovernmentFunctionPresent":false,"entrustedPerson":false,"contactDetails":{}}],"entrustedPersonsPresent":true,"entrustedPersons":[{"academicDegreeAfter":"MSc","lastName":"Jankowitsch","firstName":"Olivier","recentGovernmentFunctionPresent":false},{"academicDegreeBefore":"Dr.","lastName":"PEREZ GOMEZ","firstName":"Judith","recentGovernmentFunctionPresent":false}],"membersPresent":false,"membershipsPresent":true,"memberships":[{"membership":"Vaccines Europe"}]},"activitiesAndInterests":{"activity":{"code":"ACT_ORGANIZATION_V2","de":"Sonstiges Unternehmen","en":"Other company"},"typesOfExercisingLobbyWork":[{"code":"SELF_OPERATED_OWN_INTEREST","de":"Die Interessenvertretung wird in eigenem Interesse selbst wahrgenommen","en":"Interest representation is self-performed in its own interest"}],"fieldsOfInterest":[{"code":"FOI_ENVIRONMENT_CLIMATE","de":"Klimaschutz","en":"Climate protection"},{"code":"FOI_SCIENCE_RESEARCH_TECHNOLOGY","de":"Wissenschaft, Forschung und Technologie","en":"Science, research and technology"},{"code":"FOI_DEFENSE_OTHER","de":"Sonstiges im Bereich \"Verteidigung\"","en":"Other in the field of \"Defense\""},{"code":"FOI_FA_OTHER","de":"Sonstiges im Bereich \"Außenpolitik und internationale Beziehungen\"","en":"Other in the field of \"Foreign policy and international relations\""},{"code":"FOI_HEALTH_MEDICINE","de":"Arzneimittel","en":"Medicine"}],"activityDescription":"Valneva SE ist ein spezialisiertes Impfstoffunternehmen, das prophylaktische Impfstoffe gegen Infektionskrankheiten entwickelt, herstellt und vermarktet, die auf einen ungedeckten medizinischen Bedarf abzielen. Unsere Vision ist es, zu einer Welt beizutragen, in der niemand mehr an einer durch Impfung vermeidbaren Krankheit stirbt oder leidet. \r\nIm Austausch mit politischen Entscheidungsträgerinnen und -entscheidungsträgern setzt sich Valneva für eine bessere Impfstoffversorgung ein. Es is uns auch ein Anliegen, in Europa optimale Bedingungen zu etablieren, um hier Forschung und Entwicklung sowie Produktion von Impfstoffen zu stärken. \r\nWeiters wollen wir sicher gehen, dass Impfstoffe, die in Europa entwickelt wurden, auch dem Globalen Süden zur Verfügung stehen. \r\nLetztlich sind wir überzeugt, dass der globale Klimawandel auch einen Einfluss auf unsere Gesundheit haben wird und wir wollen in diesem Zusammenhang einen Beitrag zum weltweiten Gesundheitswesen leisten.   "},"employeesInvolvedInLobbying":{"relatedFiscalYearFinished":true,"relatedFiscalYearStart":"2024-01-01","relatedFiscalYearEnd":"2024-12-31","employeeFTE":0.0},"financialExpenses":{"relatedFiscalYearFinished":true,"relatedFiscalYearStart":"2024-01-01","relatedFiscalYearEnd":"2024-12-31","financialExpensesEuro":{"from":0,"to":0}},"mainFundingSources":{"relatedFiscalYearFinished":true,"relatedFiscalYearStart":"2024-01-01","relatedFiscalYearEnd":"2024-12-31","mainFundingSources":[{"code":"MFS_ECONOMIC_ACTIVITY","de":"Wirtschaftliche Tätigkeit","en":"Economic activity"},{"code":"MFS_PUBLIC_GRANTS","de":"Öffentliche Zuwendungen","en":"Public grants"}]},"publicAllowances":{"publicAllowancesPresent":true,"relatedFiscalYearFinished":true,"relatedFiscalYearStart":"2024-01-01","relatedFiscalYearEnd":"2024-12-31","publicAllowances":[{"name":"Republik Österreich","type":{"code":"EU_MEMBER_STATE","de":"Mitgliedstaat der EU","en":"EU Member State"},"country":{"code":"AT","de":"Österreich","en":"Austria"},"location":"Wien","publicAllowanceEuro":{"from":21490001,"to":21500000},"description":"Forschungsförderung (Forschungsprämien) für 2021"},{"name":"République Francaise","type":{"code":"EU_MEMBER_STATE","de":"Mitgliedstaat der EU","en":"EU Member State"},"country":{"code":"FR","de":"Frankreich","en":"France"},"location":"Paris","publicAllowanceEuro":{"from":890001,"to":900000},"description":"Forschungsförderung (Credit Import Recherche)"},{"name":"European Defence Fund","type":{"code":"EUROPEAN_UNION","de":"Europäische Union","en":"European Union"},"location":"Brüssel, Belgien","publicAllowanceEuro":{"from":1090001,"to":1100000},"description":"Vorauszahlung für die Teilnahme am RESILIENCE Consortium"},{"name":"CEPI - Coalition for Epidemic Preparedness Innovations","type":{"code":"THIRD_COUNTRY","de":"Drittstaat","en":"Third Country"},"country":{"code":"NO","de":"Norwegen","en":"Norway"},"location":"Oslo, Norwegen und London, UK","publicAllowanceEuro":{"from":10890001,"to":10900000},"description":"Förderung der Weiterentwicklung eines Impfstoffes gegen Chikungunya insb. für die Dritte Welt\r\nCEPI erhält Mittel von seinen Mitgliedsstaaten (darunter auch DE, AT) und auch von der Europäischen Union (Horizon)"}]},"donators":{"relatedFiscalYearFinished":true,"relatedFiscalYearStart":"2024-01-01","relatedFiscalYearEnd":"2024-12-31","totalDonationsEuro":{"from":0,"to":0}},"membershipFees":{"relatedFiscalYearFinished":true,"relatedFiscalYearStart":"2024-01-01","relatedFiscalYearEnd":"2024-12-31","totalMembershipFees":{"from":0,"to":0},"individualContributorsPresent":false,"individualContributors":[]},"annualReports":{"annualReportLastFiscalYearExists":true,"lastFiscalYearStart":"2024-01-01","lastFiscalYearEnd":"2024-12-31","annualReportPdfUrl":"https://www.lobbyregister.bundestag.de/media/24/13/626482/DEU-Financial-Report-2024-FR_c.pdf"},"regulatoryProjects":{"regulatoryProjectsPresent":false,"regulatoryProjectsCount":0,"regulatoryProjects":[]},"statements":{},"contracts":{"contractsPresent":false,"contractsCount":0,"contracts":[]},"codeOfConduct":{"ownCodeOfConduct":false}}